Synergistic potential of bone marrow mesenchymal stem cells and miR181-a combinational therapy against multiple sclerosis
This strategy takes advantage of BMSCs and miRNA and thus presents an effective synergistic strategy for the treatment of autoimmune diseases.
Authors
- Xiang Peng (ORCID: https://orcid.org/0000-0003-3453-4062)
- Xiu Xin (ORCID: https://orcid.org/0000-0002-9195-7099)
- Hulun Li (ORCID: https://orcid.org/0000-0003-2501-6861)
- Lili Mu (ORCID: https://orcid.org/0000-0002-5439-5103)
- Yanping Wang (ORCID: https://orcid.org/0000-0003-3828-1293)
- Bo Sun (ORCID: https://orcid.org/0000-0002-7999-7071)
- Wei Yu (ORCID: https://orcid.org/0000-0002-5615-9198)
- Yao Zhang (ORCID: https://orcid.org/0000-0003-3853-3550)
- Xixi Yang (ORCID: https://orcid.org/0000-0001-9839-2249)
- Junfeng Wu (ORCID: https://orcid.org/0000-0002-7125-3748)
- Sijia Chen (ORCID: https://orcid.org/0000-0001-6246-0940)
- Sifan Zhang (ORCID: https://orcid.org/0000-0002-6086-9678)
- Qingfei Kong (ORCID: https://orcid.org/0000-0002-6014-7632)
- Yumei Liu (ORCID: https://orcid.org/0009-0002-0284-260X)
- Xijun Liu (ORCID: https://orcid.org/0009-0007-7379-3901)
- Yan Wang (ORCID: https://orcid.org/0000-0002-1743-6383)
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Harbin Medical University (CN)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1186/s13287-025-04401-7
- Citations
- 2
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- Harbin Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province